Pharmaceutical Technology, Apr 1, 2009 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Apr 1, 2009
Articles
Influence of Superdisintegrants on the Rate of Drug Dissolution from Oral Solid Dosage Forms
By Jagdish Balasubramaniam , Tim Bee
The authors examine common superdisintegrants (i.e., crospovidone Type A, crospovidone Type B, croscarmellose sodium, and sodium starch glycolate) with a set of poorly soluble drug actives and evaluate in vitro drug dissolution.
Roller Compaction of Anhydrous Lactose and Blends of Anydrous Lactose with MCC
By Sander van Gessel , Henk van Duinen , Ivan Bogaerts
The authors studied the behavior of anhydrous lactose and the combination of anhydrous lactose and the combination of anhydrous lactose with microcrystalline cellulose on a pilot-scale roller compactor.
Using Polymers to Enhance Solubility of Poorly Soluble Drugs
By Kathrin Nollenberger , Andreas Gryczke , Takayuki Morita , Tatsuya Ishii
The authors demonstrate how melt-extrusion and spray-drying methods can help to prepare solid dispersions of poorly soluble drugs using Eudragit polymers.
A New Hypromellose Excipient for Direct Compression and Controlled Release
By Mark J. Hall , Brian D. Koblinski , Harold W. Bernthal , Karl V. Jacob , Kacee B. Ender
The authors examine the use of a hypromellose-based product as an excipient in a controlled release formulation using direct-compression tableting.
A Novel Pregelatinized Starch as a Sustained-Release Matrix Excipient
By Masaaki Endo , Kazuhiro Obae , Yoshihito Yaginuma
The authors examine the use of a novel highly functional pregelatinized starch as a controlled-release matrix excipient.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here